Home  >  Products  >  CNR2 (cannabinoid receptor 2 (macrophage) ) Blocking Peptide (the C terminal of CNR2)(100ug)
CNR2 (cannabinoid receptor 2 (macrophage) ) Blocking Peptide (the C terminal of CNR2)(100ug)

CNR2 (cannabinoid receptor 2 (macrophage) ) Blocking Peptide (the C terminal of CNR2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CNR2 Antibody (ARP63486_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63486
Size: 100ug
Weight: 40kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
Alternative names: CB2; CX5
See Full Product Listings >